Speaker - Ben Cacace, Senior R&D Engineer
Having challenges optimizing your virus clearance filter capacity and flux? Join us for our upcoming webinar to learn how prefiltration technologies can provide significant increases in the performance of your viral clearance filter.
Size exclusion based filtration provides critical viral clearance assurance in biopharmaceutical production processes. Although process intermediates are highly purified prior to viral clearance filtration, the presence of protein aggregates, denatured proteins and other trace fouling species can negatively impact the hydraulic performance of virus filters, increasing the required filtration area. Implementing a robust prefiltration step will clear these fouling species, leading to significant improvements in virus filter capacity, flux and an overall decrease in viral filtration costs.
In this webinar, you will learn:
- How feed aggregates and other impurities can negatively impact virus filter performance
- How prefiltration strategies can effectively and significantly increase virus filter capacity and flux while reducing costs
How to select the best prefiltration technology for your given bioprocess.